SK Biopharm seeks USFDA’s approval for new drug candidate

SEARCH
MOBILE

Market Now

SK Biopharm seeks USFDA’s approval for new drug candidate

PUBLISHED :November 26, 2018 - 12:47
UPDATED :November 26, 2018 - 12:47

[DISCLOSURE] SK (034730) announced on Nov. 26 that its subsidiary SK Biopharm has handed in new drug application for US Food and Drug Administration’s approval for its novel epilepsy drug candidate Cenobamate.

By Hwang You-mee (glamazon@heraldcorp.com)

BACK TO LIST TOP

April 27, 2024

Market Now

SK Biopharm seeks USFDA’s approval for new drug candidate

EDITOR'S PICKS